MSD
For over 130 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of their mission to save and improve lives. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A.
See below for the Latest MSD News, Analysis, Profit Results, Share Price Information, and Commentary.
MSD navigates the pandemic tapestry in COVID-19 fight
MSD navigates the pandemic tapestry in COVID-19 fight
It has navigated the complexities of the challenging period through a proactive approach.
Join the community
Most Read
1. Singapore’s AI tool analyses heart attack damage within one minute 2. APAC turns to AI as healthcare worker shortfall nears 11 million 3. HKUMed pioneers robot-assisted living-donor liver transplant 4. Medical Taiwan 2026 closes with $168.7m in business opportunities 5. Apollo Hospitals expands India footprint with 200-bed facilityResource Center
Partner Events
Event News
Medical Taiwan 2026 closes with $168.7m in business opportunities
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential
Why health system research deserves more attention